Phibro Animal Health PAHC
NASDAQ PAHC
$34.45 -0.85 (-2.41%)
As of: Sep 17, 2026 · 3:59 PM EDT

Phibro Animal Health (PAHC) Total Non-Current Liabilities (2013 - 2026)

Phibro Animal Health (PAHC) posted Total Non-Current Liabilities of $1.0 billion for Q2 2026, up 2.98% on a QoQ basis from $994.6 million in Q1 2026, and up 2.84% year-over-year from $995.9 million in Q2 2025.

Analysis

Phibro Animal Health (PAHC) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends

Phibro Animal Health has reported Total Non-Current Liabilities for 14 years, with the latest figure at $1.0 billion in Q2 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 2.84% year-over-year to $1.0 billion in Q2 2026; TTM through Jun 2026 was $1.0 billion, a 2.84% increase from a year earlier, with the FY2026 full-year figure at $1.0 billion, up 2.84% from the prior year.
  • Total Non-Current Liabilities was $1.0 billion for Q2 2026 at Phibro Animal Health, up from $994.6 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $1.0 billion in Q2 2026, with the low at $587.7 million in Q1 2022.
  • Average Total Non-Current Liabilities over 5 years is $771.0 million, with a median of $644.3 million recorded in 2024.
  • The sharpest annual moves came in 2023 and 2025: Total Non-Current Liabilities grew 1.09% in 2023, then soared 54.55% in 2025.
  • Over 5 years, Total Non-Current Liabilities stood at $628.4 million in 2022, then rose by 1.31% to $636.6 million in 2023, then surged by 52.4% to $970.1 million in 2024, then grew by 2.35% to $993.0 million in 2025, then gained by 3.15% to $1.0 billion in 2026.
  • The last three Total Non-Current Liabilities figures came in at $1.0 billion (Q2 2026), $994.6 million (Q1 2026), and $993.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Idexx Laboratories 40.57 Bn 40.38 Bn 779.09 Mn 542.10 Mn
2 Zoetis 30.57 Bn 28.90 Bn 1.05 Bn 11.64 Bn
3 Elanco Animal Health 11.47 Bn 10.94 Bn 798.00 Mn 6.42 Bn
4 Phibro Animal Health 1.43 Bn 1.35 Bn 134.40 Mn 1.02 Bn
5 Immucell 87.38 Mn 78.52 Mn 2.44 Mn 10.82 Mn
6 Zhengye Biotechnology Holding 64.40 Mn 57.30 Mn - 1.31 Mn
7 Global Innovative Platforms 24.88 Mn 24.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.02 Bn
Mar 31, 2026 994.56 Mn
Dec 31, 2025 992.97 Mn
Sep 30, 2025 994.66 Mn
Jun 30, 2025 995.91 Mn
Mar 31, 2025 977.64 Mn
Dec 31, 2024 970.13 Mn
Sep 30, 2024 643.56 Mn
Jun 30, 2024 662.44 Mn
Mar 31, 2024 645.08 Mn
Dec 31, 2023 636.59 Mn
Sep 30, 2023 631.07 Mn
Jun 30, 2023 628.54 Mn
Mar 31, 2023 631.32 Mn
Dec 31, 2022 628.38 Mn
Sep 30, 2022 624.24 Mn
Jun 30, 2022 608.76 Mn
Mar 31, 2022 587.72 Mn
Dec 31, 2021 553.95 Mn
Sep 30, 2021 546.60 Mn